Key result
Intracoronary infusion of ET-1 decreased coronary blood flow per unit of interstitial space by approximately 30% and increased myocardial microcirculatory transit times.
Why the study?
Does intracoronary infusion of endothelin-1 affect coronary microcirculatory exchanges and myocardial metabolism in anesthetized dogs?
Does intracoronary infusion of endothelin-1 affect coronary microcirculatory exchanges and myocardial metabolism in anesthetized dogs?
Pharmacological doses of endothelin-1 may adversely affect myocardial metabolism by reducing blood flow and capillary permeability for small circulating substances.
Answers are grounded in this paper and cite their sources.
May impair canine myocardial metabolism via reduced microcirculatory flow; leaves open endothelin’s role in human coronary dysfunction.
Myocardial metabolism of endothelin-1 (ET-1) and its effect on coronary microcirculatory exchanges were obtained in anesthetized dogs by combining the indicator-dilution technique with immunoreactive ET-1 measurements. The myocardium extracted 17.7 +/- 4.6% of tracer ET-1 (n = 12). Simultaneously measured ET-1 levels in the aorta (0.97 +/- 0.46 pg/ml) and coronary sinus (0.96 +/- 0.53 pg/ml) were not different, supporting a production of ET-1 by the heart that balances the amount extracted. Intracoronary infusion of ET-1 (5 ng.kg-1.min-1) increased coronary sinus ET-1 levels approximately 50-fold, decreased coronary blood flow per unit of interstitial space by approximately 30% (P = 0.006), and increased myocardial microcirculatory transit times (n = 6). Permeability to albumin was unaffected by ET-1, whereas the permeability-surface area product for sucrose decreased following derecruitment of myocardial capillaries. We conclude that there is a normal myocardial metabolic balance of ET-1 and that the heart marginally contributes to circulating ET-1. Pharmacological doses of ET-1 may adversely affect myocardial metabolism by reducing blood flow and the permeability-surface area product for small circulating substances.
No takes yet. Share an insight, caveat, or question.
Dupuis et al. (1997) studied this question. Intracoronary infusion of endothelin-1 (ET-1) was evaluated on Coronary blood flow per unit of interstitial space (decreased by approximately 30%, p=0.006). Intracoronary infusion of ET-1 decreased coronary blood flow per unit of interstitial space by approximately 30% and increased myocardial microcirculatory transit times.
Synapse has enriched 10 related papers. Consider them for comparative context: